Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Epigenomes
|
December 30, 2021
Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma
Joyce K Thompson, Filip Bednar
Journal of Cellular Biochemistry
|
August 21, 2013
Malignant mesothelioma: development to therapy
Joyce K Thompson, Catherine M Westbom, Arti Shukla
The American Journal of Pathology
|
January 6, 2017
Asbestos-Induced Mesothelial to Fibroblastic Transition Is Modulated by the Inflammasome
Joyce K Thompson, Maximilian B MacPherson, Stacie L Beuschel, et al.
Plos One
|
December 23, 2015
Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma
Catherine Westbom, Joyce K Thompson, Alan Leggett, et al.
Particle and Fibre Toxicology
|
June 3, 2014
Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation
Joyce K Thompson, Catherine M Westbom, Maximilian B MacPherson, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 17, 2014
Curcumin: a double hit on malignant mesothelioma
Jill M Miller, Joyce K Thompson, Maximilian B MacPherson, et al.
Oncotarget
|
February 9, 2018
Extracellular signal regulated kinase 5 and inflammasome in progression of mesothelioma
Joyce K Thompson, Anurag Shukla, Alan L Leggett, et al.
American Journal of Respiratory Cell and Molecular Biology
|
June 19, 2014
Extracellular signal-regulated kinase 5 and cyclic AMP response element binding protein are novel pathways inhibited by vandetanib (ZD6474) and doxorubicin in mesotheliomas
Mutlay Sayan, Arti Shukla, Maximilian B MacPherson, et al.
Particle and Fibre Toxicology
|
August 14, 2013
Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells
Jedd M Hillegass, Jill M Miller, Maximilian B MacPherson, et al.
Nature Communications
|
October 17, 2024
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma
Nneka E Mbah, Amy L Myers, Peter Sajjakulnukit, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Epigenomes
|
December 30, 2021
Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma
Joyce K Thompson, Filip Bednar
Journal of Cellular Biochemistry
|
August 21, 2013
Malignant mesothelioma: development to therapy
Joyce K Thompson, Catherine M Westbom, Arti Shukla
The American Journal of Pathology
|
January 6, 2017
Asbestos-Induced Mesothelial to Fibroblastic Transition Is Modulated by the Inflammasome
Joyce K Thompson, Maximilian B MacPherson, Stacie L Beuschel, et al.
Plos One
|
December 23, 2015
Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma
Catherine Westbom, Joyce K Thompson, Alan Leggett, et al.
Particle and Fibre Toxicology
|
June 3, 2014
Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation
Joyce K Thompson, Catherine M Westbom, Maximilian B MacPherson, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 17, 2014
Curcumin: a double hit on malignant mesothelioma
Jill M Miller, Joyce K Thompson, Maximilian B MacPherson, et al.
Oncotarget
|
February 9, 2018
Extracellular signal regulated kinase 5 and inflammasome in progression of mesothelioma
Joyce K Thompson, Anurag Shukla, Alan L Leggett, et al.
American Journal of Respiratory Cell and Molecular Biology
|
June 19, 2014
Extracellular signal-regulated kinase 5 and cyclic AMP response element binding protein are novel pathways inhibited by vandetanib (ZD6474) and doxorubicin in mesotheliomas
Mutlay Sayan, Arti Shukla, Maximilian B MacPherson, et al.
Particle and Fibre Toxicology
|
August 14, 2013
Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells
Jedd M Hillegass, Jill M Miller, Maximilian B MacPherson, et al.
Nature Communications
|
October 17, 2024
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma
Nneka E Mbah, Amy L Myers, Peter Sajjakulnukit, et al.
Page
of 1